NVTA Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (14 Feb 2024 @ 15:59):

Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally...

Stats
Today's Volume	22.46M
Average Volume	12.70M
Market Cap	5.44M
EPS	$0 ( 2024-02-27 )
Next earnings date	( $0 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.00354
ATR14	$0.0380 (237.50%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-20	Nussbaum Robert L	Sell	17 404	Common Stock
2023-12-20	Brida Thomas	Sell	17 404	Common Stock
2023-11-13	Sholehvar David	Buy	850 000	Common Stock
2023-11-13	Sholehvar David	Buy	0
2023-10-18	Brida Thomas	Buy	229 500	Common Stock

INSIDER POWER
90.35
Last 92 transactions
Buy: 9 089 738 \| Sell: 529 241

Volume Correlation

Long: -0.23 (neutral)

Short: -0.96 (very strong negative)

Signal:(21.881) Possible Trading Opportunity Present (swing)

Invitae Corp Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Invitae Corp Correlation - Currency/Commodity

-0.39
( neutral )

-0.29
( neutral )

0.00
( neutral )

0.46
( neutral )

-0.41
( neutral )

-0.30
( neutral )

Invitae Corp Financials

Annual	2022
Revenue:	$516.30M
Gross Profit:	$99.05M (19.18 %)
EPS:	$-13.18

Q3	2023
Revenue:	$121.24M
Gross Profit:	$39.06M (32.21 %)
EPS:	$-3.42

Q2	2023
Revenue:	$120.53M
Gross Profit:	$33.06M (27.43 %)
EPS:	$-0.780

Q1	2023
Revenue:	$117.36M
Gross Profit:	$28.91M (24.64 %)
EPS:	$-0.770

Financial Reports:

No articles found.

Invitae Corp

Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.